Insider Selling: Dave Teitel Sells 10,000 Shares of Alere Stock (ALR)
Alere (NYSE:ALR) CFO Dave Teitel sold 10,000 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $35.07, for a total value of $350,700.00. Following the sale, the chief financial officer now directly owns 5,002 shares of the company’s stock, valued at approximately $175,420. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Alere from $45.00 to $40.00 in a research note on Tuesday, August 5th. They now have a “buy” rating on the stock. Separately, analysts at Leerink Swann cut their price target on shares of Alere from $40.00 to $38.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of Alere from $50.00 to $45.00 in a research note on Tuesday, August 5th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $42.60.
Shares of Alere (NYSE:ALR) traded up 0.29% on Monday, hitting $34.82. 368,075 shares of the company’s stock traded hands. Alere has a 1-year low of $30.14 and a 1-year high of $40.80. The stock’s 50-day moving average is $37.64 and its 200-day moving average is $36.23. The company’s market cap is $2.893 billion.
Alere (NYSE:ALR) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.42 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.58 by $0.16. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $747.55 million. During the same quarter in the prior year, the company posted $0.64 earnings per share. The company’s quarterly revenue was down 3.4% on a year-over-year basis. Analysts expect that Alere will post $2.23 EPS for the current fiscal year.
Alere Inc is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.